• Folic Acid, CD36, and Toxoplasma Vascular Injury

  2026-08-07

  A 2026 study identifies a CD36–autophagy-lysosomal pathway through which Toxoplasma gondii antigens impair endothelial and vascular integrity, and shows that prophylactic folic acid limits this response in mice and human vascular organoids. The work provides a mechanistic framework for studying antigen-driven vascular injury beyond direct parasite invasion.

• TIA1-CLSTN1 Splicing Axis Drives EMT and Breast Cancer Metas

  2026-08-07

  This study identifies TIA1 as a suppressor of CLSTN1 exon 11 inclusion, revealing a novel post-transcriptional mechanism that facilitates epithelial-to-mesenchymal transition (EMT) and breast cancer metastasis. These findings offer new insights into alternative splicing regulation in cancer progression and highlight potential therapeutic targets for metastatic disease.

• Universal nPEC Method for Dual-Loaded Liposome Encapsulation

  2026-08-06

  This study introduces a nanoparticle exclusion chromatography (nPEC) method for accurately and efficiently determining encapsulation efficiency in dual-loaded liposomes containing both hydrophilic and lipophilic drugs. The findings address a critical bottleneck in liposomal drug delivery research, enabling standardization and improved reproducibility across combination formulation studies.

• Sumatriptan Succinate: Advanced Workflows in 5-HT1 Research

  2026-08-06

  Sumatriptan Succinate, a selective 5-HT1 receptor agonist, is revolutionizing both migraine and inflammation model workflows with its dual pharmacological profile. Discover protocol enhancements, translational applications, and troubleshooting strategies to maximize experimental precision with this APExBIO gold-standard compound.

• Praeruptorin A Suppresses NF-κB and Inflammatory Genes in Ma

  2026-08-05

  This study demonstrates that Praeruptorin A, a coumarin from Radix peucedani, potently inhibits NF-κB pathway activation and the expression of key inflammatory mediators in poly (I:C)-stimulated RAW264.7 macrophages. These findings refine inflammation assay models and highlight new strategies for targeting virus-related inflammatory responses in research.

• MnTBAP Chloride in Neuroinflammation: Mechanistic Insights f

  2026-08-05

  Explore how MnTBAP Chloride, a potent SOD mimetic, advances neuroinflammation and mitochondrial dysfunction research. This article delivers a mechanistic, evidence-based perspective distinct from standard redox assay protocols.

• Biomimetic Chromatography for Pulmonary Drug Permeability Mo

  2026-08-04

  This study systematically compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for evaluating drug partitioning and predicting pulmonary permeability. The findings offer critical methodological guidance for respiratory drug development, clarifying the strengths and limitations of each technique.

• Ciclesonide in Bench Research: Protocols, Applications, and

  2026-08-04

  Ciclesonide unlocks precision modeling in asthma and transmembrane protein research through rapid prodrug activation and potent glucocorticoid receptor engagement. This article details experimental workflows, troubleshooting strategies, and the latest ERAD-hijacking advances, ensuring reliable and reproducible results for respiratory and targeted protein degradation studies.

• Biomimetic Chromatography Advances Pulmonary Drug Permeabili

  2026-08-03

  The reference study introduces a robust comparison of biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), both coupled with mass spectrometry, for modeling lung permeability of pharmaceuticals. This work offers new analytical strategies for respiratory drug development, enabling high-throughput, physiologically-relevant assessment of pulmonary absorption and membrane interactions.

• Gamma-linolenic Acid (GLA): Novel Insights Into Immunomodula

  2026-08-03

  Explore the multifaceted role of gamma-linolenic acid (GLA) in modulating inflammation and immune responses. This in-depth article uncovers advanced mechanisms and experimental strategies, setting a new standard for anti-inflammatory research with GLA.

• Sulfaphenazole: From CYP2C9 Inhibition to Translational Impa

  2026-08-02

  This thought-leadership article examines Sulfaphenazole’s mechanistic and strategic value for translational researchers. It integrates evidence on cytochrome P450 2C9 inhibition, vascular function restoration, and antibacterial applications, with actionable guidance on experimental design, protocol parameters, and cross-domain considerations. By critically analyzing structure-activity optimization and positioning APExBIO’s Sulfaphenazole (C4131) within the evolving research landscape, the article empowers teams to bridge laboratory insights with clinical translation.

• Metoprolol in Modern Research: Beyond Beta1 Selectivity

  2026-08-01

  Explore how Metoprolol, a selective beta1-adrenoceptor antagonist, empowers advanced research in cardiovascular disease, inflammation, and cancer biology. This in-depth review uncovers new assay considerations and differentiates Metoprolol’s applications from conventional approaches.

• Triazole ALDH2 Activators: Advancing Therapy for Myocardial

  2026-07-31

  The referenced study introduces novel triazole-based aldehyde dehydrogenase 2 (ALDH2) activators with superior water solubility and activation potency, addressing a major therapeutic gap in myocardial ischemia-reperfusion injury. By optimizing molecular structure, the authors demonstrate unprecedented efficacy in restoring cardiac function and reducing infarct size in preclinical models, offering a compelling new avenue for targeted myocardial protection.

• nor-NOHA Acetate: Precision Arginase Inhibition in Tumor Imm

  2026-07-31

  Explore how nor-NOHA acetate, a potent arginase inhibitor, uncovers new dimensions in tumor immune evasion and metabolic regulation. This article uniquely connects nor-NOHA's mechanistic impact to practical assay design and recent advances in AML immunometabolism.

• Chronic Stress, Mitochondrial Dysfunction, and Neuroinflamma

  2026-07-30

  This study demonstrates that chronic unpredictable mild stress (CUMS) induces depression-like behavior in rats through disruption of brain mitochondrial function and heightened neuroinflammation. Importantly, targeted antioxidant intervention with MnTBAP ameliorated both behavioral and biochemical deficits, highlighting mitochondrial redox modulation as a promising avenue for depression research.

15555 records 1/1037 page Next 12345 下5页 Last page